Hans Rosling famously declaimed that there is no skill which the professionals of the developing world cannot apply -given the training, equipment and funding. The privilege of working and teaching in many countries has confirmed this for many. The backlog of treatable blindness can and should ultimately be managed by the local communities and their support teams. The role of good neighbours is to support the transition to independence. Such support cannot rigidly enforce systems with which we are familiar and comfortable if they are to be effective. Our perceptions of the "best" options must not exclude good, sound alternatives. There is an extraordinary resourcefulness within these communities. Appropriate, affordable and sustainable technology combine well with clinical skills and in-depth knowledge of basic sciences. One can and must devise realistic ways to investigate and treat refractive errors, cataracts, glaucoma, headaches and many other challenges. Glaucoma is characterized by optic nerve fiber atrophy and damage to the optic nerve head which results in the deterioration of the visual field and vision loss. Elevated intraocular pressure (IOP) is currently known as the primary and only evidence-based, treatable risk factor for open angle glaucoma. Glaucoma is suspected to be a multifactorial disease with IOP-dependent and IOPindependent risk factors. Traditional risk factors for glaucoma include family history and ethnicity. The risk of glaucoma also increases with advancing age. There is growing evidence supporting the roles of other factors that predispose a person to glaucoma damage, including circulation to the eye and optic nerve. These "non-traditional" risk factors include low blood pressure or perfusion pressure and other vascular factors. There are also a number of lifestyle factors that may contribute to the development of glaucoma through their direct influence on IOP and/or through other mechanisms of glaucomatous optic neuropathy. The role of these modifiable risk factors will be reviewed using evidence in the current literature.
0815-0845 P01 -ANNUAL GENERAL MEETING
The Best practice feedback which focusses on tasks, process and self-regulation has been shown to improve performance by 26%. Recent enhancements to supervisor feedback documentation in the Vocational Training Program (VTP) facilitate early intervention while ensuring consistency specifically with regards to feedback between the numerical rating and the qualitative feedback as well as closing the trainees' learning loop. This session will revisit the 2016 -2017 changes in ratings, in particular the specific criteria assigned to all CanMEDS roles where a trainee has been rated as borderline or inferior. The support provided by RANZCO's VTP team for supervisors will be showcased including recent upgrades to the clinical tutors and term supervisors' resources and support sections within the learning management system (Moodle).
1130-1200 L02 -Cataract Udate Lecture Dr Bonnie An Henderson
Topic: Negative Dysphotopsias -The Unsolved Mystery Chair: Dr Arthur Karagiannis Venue: Riverside Theatre Synopsis:
The appearance of a dark shadow in the temporal periphery, otherwise known as negative dysphotopsia, continues to be a problem for some patients after routine uncomplicated cataract surgery. Etiologies include type and design of intraocular lens (IOL), anatomical features and dimensions of the eye, pupil size, angle kappa, relationship of the optic to the anterior capsule, and the position of the optic/haptic junction of the IOL. Although the primary etiology remains controversial, it is clear that the cause is multifactorial. A new preventative approach will be introduced.
1200-1230 L03 -Glaucoma Update Lecture
Dr Anne L Coleman Topic: Looking Beyond Traditional Risk Factors Chair: Dr Catherine Green AO Venue: Riverside Theatre Synopsis: Glaucoma is characterized by optic nerve fiber atrophy and damage to the optic nerve head which results in the deterioration of the visual field and vision loss. Elevated intraocular pressure (IOP) is currently known as the primary and only evidence-based, treatable risk factor for open angle glaucoma. Glaucoma is suspected to be a multifactorial disease with IOP-dependent and IOPindependent risk factors. Traditional risk factors for glaucoma include family history and ethnicity. The risk of glaucoma also increases with advancing age. There is growing evidence supporting the roles of other factors that predispose a person to glaucoma damage, including circulation to the eye and optic nerve. These "non-traditional" risk factors include low blood pressure or perfusion pressure and other vascular factors. There are also a number of lifestyle factors that may contribute to the development of glaucoma through their direct influence on IOP and/or through other mechanisms of glaucomatous optic neuropathy. The role of these modifiable risk factors will be reviewed using evidence in the current literature.
1230-1400 LUNCH

1400-1530 CONCURRENT SESSIONS
1400-1530 S01 -RANZCO: Ethics and Professionalism: Crossing the Line Chair: Dr Arthur Karagiannis Venue: Bellevue Ballroom 1 Outline: This session will focus on issues of ethics and professionalism that face all ophthalmologists as they run their businesses. Your relationship with industry, collaborative partners and the regulatory authorities will be explored. The rise of defensive medicine and the main reasons you might be sued will be covered. Anyone who undertakes, or is considering undertaking, international development or outreach work will also be interested to hear about ethics and professionalism within these spaces. Purpose: To use all available glaucoma cases through the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG), in combination with published data on quantitative trait loci for optic disc and IOP parameters in normal individuals to identify new glaucoma susceptibility genes. Methods: We performed a genome-wide association study in 3071 OAG cases and 6750 unscreened controls, and meta-analysed the results with publicly available GWAS data for intraocular pressure (IOP) and optic disc parameters, the known risk factors for OAG. Results: We identified and validated four novel genome-wide significant associations within or near MYOF/CYP26A1, LINC02052/CRYGS, LMX1B, and LMO7 using single variant tests, one additional locus complement factor 9 (C9) using gene-based tests, and two genetic pathways in pathway-based tests; "response to fluid shear stress" (P=2.09e-07, FDR<0.01) and "abnormal retina morphology" (P=2.50e-07, FDR<0.01). Interestingly, some of the new risk loci contribute to risk of other geneticallycorrelated eye diseases including myopia and agerelated macular degeneration. LMX1B is also mutated in a mouse model of glaucoma, and Nail-Patella Syndrome, characterised by nail, patella and elbow dysplasia, in which some patients are known to develop OAG. Conclusion: This study has identified five new OAG risk loci and two genetic pathways, and highlighted the future potential of combining genetic data from genetically correlated eye traits for the purpose of gene discovery and mapping. Purpose: To assess the long term safety and effectiveness of cross-linked gelatin microfistula surgery in a cohort of high risk glaucoma patients. Method: 23 eyes of 21 patients with open angle glaucoma were included. 22 had undergone prior trabeculectomy or glaucoma drainage device surgery and 21 had undergone prior cataract extraction. All subjects underwent ab-interno implantation of a cross-linked gelatin microfistula tube from the anterior chamber to the subconjunctival space. This was developed in our laboratory and later commercialized as XEN (Allergan). Intraocular pressure (IOP), drug use and number of needlings were assessed at annual intervals over six years. Survival analysis using IOP less than or equal to 21 mmHg was the prime measure. Safety measures included best corrected visual acuity, slit lamp observations, complications and adverse events. Results: The average followup time after gelatin microfistula insertion was 6.09 (sd 0.8) years. Mean pre-operative IOP was 25 mmHg (sd 5.5) with sixyear post-operative intraocular pressure of 13.4 (sd 2.8) mmHg, using an average 0.5 medications compared to 3 medications pre-operatively. At six years 82% had intraocular pressure less than 21 mmHg with 41% having IOP less than 21 mmHg off all therapy. Best corrected visual acuity improved in four eyes with three having deteriorating acuity, one of which was due to worsening glaucoma. Mean intraocular pressure reduction was 38% at the final visit. Conclusion: At mean six years, significant IOP reduction was seen with reduced need for medications. The procedure appears safe. Purpose: To establish medium-term repeatability of the iPad perimetry app Melbourne Rapid Fields (MRF) compared to Humphrey Field Analyzer (HFA) 24-2 SITA-Standard and HFA 24-2 SITA-Fast. Methods: 62 patients (stable mild to severe glaucoma/ocular hypertension/glaucoma suspects) were recruited into a 6-month longitudinal clinical study at two glaucoma clinics (India, Cambridge) with visits at baseline, 2, 4 and 6 months. One eye of each patient is randomly selected for the study if selection criteria were met. At each visit patients undertook supervised visual field assessment in the same eye using MRF radial-pattern threshold test and either HFA SITA-Fast (n=25) or SITA-Standard (n=37). Exclusion criteria: visual acuity worse than 6/12, intraocular surgery in past 6 months or poor reliability indices on HFA at baseline. Results: MRF was similar to SITA-Fast in speed and significantly faster than SITA-Standard (MRF 4.2AE0.1 vs. SITA-Fast 3.8AE0.1 vs. SITA-Standard 6.1AE0.1 min, p<0.001). Pearson's correlation between MRF and SITA-Fast for Mean Deviation (MD) at the four visits ranged from 0.928 to 0.946. Correlation between MRF and SITA-Standard for MD ranged from 0.884 to 0.925. Test-retest repeatability of MRF outcomes gave 95% Limits of Agreement (LoA) after 2, 4 and 6 months of 4.7, 6.7, and 7.7 dB respectively. In comparison, 95% LoA for MD generated by 9.8, 8.8 dB) and 9.8, 8.5 dB) for the same time points were on average 40% greater (Levene's testp=0.027 SITA-Fast, p=0.018 SITA-Standard). Conclusion: MRF correlated strongly with HFA across 4 visits over a 6 month time period; it also has good test-retest reliability. MRF is, therefore, a highly portable technology that is suitable for monitoring the visual fields of patients with glaucoma in clinical settings. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore, 7 Duke-NUS Medical School, National University of Singapore, Singapore, Singapore Aim: To measure the impact of patient-centred glaucoma-related education on patient knowledge, anxiety and treatment satisfaction. Design: Multicentre Australia-wide randomised clinical trial. Participants: 101 newly-diagnosed glaucoma patients randomised 1:1 to intervention or control groups. Methods: Those randomised to the Glaucoma Australia educational intervention received telephone-based counselling about glaucoma followed by mail out information, in addition to usual care and information from their treating ophthalmologist. The control group received only usual care and information from their treating ophthalmologist. Surveys were administered at baseline and 4-weeks following intervention. Main outcome measures: The Auckland Glaucoma Knowledge Questionnaire (AGKQ) measured glaucoma related knowledge. The Hospital Anxiety and Depression Scale (HADS) and Eye Drop Satisfaction Questionnaire (EDSQ) measured anxiety and patient treatment satisfaction, respectively. Results: Mean (standard deviation [SD] ) age of all 101 participants was 64.7 (11.1) years and 52 (51.5%) were male. There was no noticeable increase in knowledge levels in the control group (mean difference: 0.04 logits, P = 0.7), compared with 0.49 logits (P = 0.02) increase in knowledge levels in the intervention group. Between group comparison showed a non-significant increase in level of knowledge (0.45 logits, P = 0.07) comparing intervention participants with controls. Intervention participants experienced a statistically significant decrease in anxiety levels compared to control participants (-0.60 logits, P = 0.02). No differences were found in EDSQ scores between the two groups. Conclusion: Patient-centred glaucoma-related education and support services may improve knowledge levels and can reduce anxiety levels for newly diagnosed patients with glaucoma. Purpose: To assess the visual scanning behaviour and closed-road driving performance of older drivers with glaucomatous visual impairment. Method: Participants included 13 older drivers with glaucomatous visual impairment (mean age=72AE 7 years; average better-eye mean deviation (MD)= −3AE2 dB, average worse-eye MD=−13AE7 dB) and ten visually-normal controls (mean age=71AE7 years). Visual acuity, contrast sensitivity, visual fields, useful field of view (UFoV), and motion sensitivity were assessed. Participants drove around a closed-road circuit while their eye movements were recorded with an ASL Mobile Eye-XG. Driving performance measures included hazard avoidance, sign recognition, and lane-crossing time; overall driving z-score was derived from these three component measures. Results: Glaucoma participants had significantly poorer overall driving scores than the controls (0.1 vs 0.4; p=0.018) and hit almost twice the number of hazards compared to controls (24% vs 13%; p=0.043). The glaucoma group also exhibited larger saccade amplitudes (p<0.001), horizontal (p<0.001) and vertical search variances (p=0.002) than controls. Larger saccades were associated with better overall driving scores in the glaucoma group (p=0.001), but not the controls (p=0.65). Across all participants, the strongest visual predictor of overall driving score was better-eye MD (p<0.001), followed by binocular Esterman, integrated visual fields, worse-eye MD, dot motion sensitivity, contrast sensitivity, and the UFoV subtest 2 (p<0.05). Conclusion: Drivers with glaucoma had poorer driving performance than the controls and demonstrated differences in eye movement patterns, where larger saccades were associated with better driving scores. These findings suggest that altered scanning behaviours may benefit driving performance and safety in drivers with glaucoma. Background: Glaucoma occurs in 5% of south east Asian people over the age of 40 and blinds 1 in 5. Many have trabeculectomy, which tend to fail. Ideally, they require a glaucoma drainage device (GDD) but this costs approximately US$1,000 and is too expensive. Methods: We designed a non-valved GDD made of polymethyl-methacrylate plate connected to a silicone tube that is cheap to manufacture and sterilize locally. We assessed the inflammatory and histological reaction in 10 rabbits out to 60 days finding no clinically significant inflammation and capsule formation comparable to other GDD published results. We then began implanting these into patients with severe secondary forms of glaucoma and have follow them in excess of 6 months Results: 70 patients with uveitic (20%), neovascular (30%), silicone oil induced (25%) with the rest being other forms of glaucoma having failed trabeculectomy with antimitotics. No vision threatening complications have been seen, inparticular no endophthalmitis. Mean preoperative IOP was 39 (n = 70), mean IOP at 3 months was 17mmHg (n = 31) and mean IOP at 6 months was 18 mmHg (n = 20). All transient hypotony resolved and clinically, the post-operative appearance was similar to other GDD. Two patients with visual field reduction to 10 degrees maintained acuity of 6/9 for one year.
Conclusion:
The new GDD has good short term IOP reduction characteristics and is safe and well tolerated in the short term. We plan to assess its longer term results and hope to encourage its use across Indonesia. Method: Retrospective notes review of the last 10 years. Each patient was identified as a first presentation of bilateral optic nerve head swelling with computer tomography venography (CTV) and/or magnetic resonance venography (MRV) performed prior to undergoing lumbar puncture. Fourteen imaging findings were assessed for from written radiology reports. Statistical analysis was undertaken with machine learning algorithms used to reanalyse the data. Results: 175 patients were retrospectively identified. Overall MRV (75.6%) was more sensitive than CTV (64%) but less specific (MRV 76.9%, CTV 84.2%) and had a lower posiive predictive value (PPV) (MRV 91.9%, CTV 94.2%). Transverse sinus narrowing was seen to have the highest sensitivity for both CTV (48.1%) and MRV (59.6%). Specificities for individual imaging findings were all above 95% for CTV and 93% for all but one MRV finding. Combinations of CTV imaging findings increased sensitivity while maintaining specificity and PPV above 90%. Combined MRV imaging findings increase sensitivity while maintaining a specificity above 80% and a PPV of 92% or greater. There was a low false discovery rate for all imaging findings. However, the absence of findings did not exclude a diagnosis of IIH. Machine learning algorithms outperformed standard statistical analysis and univariate and multivariate logistic regression analysis with sensitivity and specificity both above 90%. Conclusion: CTV and MRV demonstrate high specificity and positive predictive values for a diagnosis of IIH. However, given the high false negative values, the absence of imaging findings did not rule Purpose: Fundoscopy is performed infrequently outside of ophthalmology and neurology. These examinations can facilitate a screening and diagnosis, assisting in triage and referral. The decline in fundoscopy has been ascribed to technical examination challenges and difficulty interpreting results. We hypothesise that capturing fundus photos using smartphones would minimise these challenges and increase clinical use. Methods: 38 second and final-year medical students participated. They accessed a fundus interpretation eLearning course, and were exposed to three devices for fundoscopy: direct ophthalmoscopy; and two smartphone adaptors: the Panopthalmoscope-iExaminer, and D-eye. They completed examinations on simulators and patients, with a crossover between smartphone and direct fundoscopy. Following they were surveyed on: preferred technique for fundoscopy; confidence; and ease of viewing the fundus. Further sessions with another 90 students are pending. Data analysis used one-sample t-test, binomial test, and Wilcoxon signed-rank test. Results: 32 students (84.2%) completed the postworkshop questionnaire. Clinical interpretation results are pending. Overall, students responded favourably to smartphone-assisted fundoscopy (SF) over direct ophthalmoscopy (DO). 75% preferred SF over DO (p = 0.007), Confidence levels viewing fundus on a 1-5 Likert scale (1 being least confident) was 3.500 (95% CI[3.17-3.83]) for SF vs 3.031 (95% CI [2.69-3.37]) for DO (p = 0.037). Ease of viewing fundus was 3.469 (95% CI [2.14-2.80]) for sSF and 2.844 (95% CI [2.49-3.20]) for DO (p =0.037).
Smartphone-assisted fundoscopy enhances medical students confidence in fundus examinations and allows easier fundus viewing. Further studies will determine how this translates to long-term clinical use. Purpose: The lack of biological models for inherited retinal diseases is a major barrier to the elucidation of disease pathogenesis and the discovery of novel treatments. Here we report the characterization of an induced pluripotent stem cell model for retinitis pigmentosa caused by a novel CLN3 mutation. Methods: A skin biopsy from a patient with clinically and genetically diagnosed CLN3 mutation was used to establish primary fibroblast cultures. Patient fibroblasts were reprogrammed to pluripotency using an episomal system. An isogenic control line was established by CRISPR/Cas gene editing to remove the disease-causing mutation. Patient and control cells were analysed by western blotting and quantitative PCR. Results: The patient-derived line and isogenic control line were established successfully. Pluripotent stem cells could be differentiated into retinal, neural and cardiomyocyte lineages. Patient-derived cells were shown to display hallmarks of disease pathology, including lysosomal defects, vacuolization and accumulation of mitochondrial ATPase subunit C. Correction of the novel CLN3 mutation abolished accumulation of ATPase subunit C. Furthermore, we found that the novel missense mutation in CLN3 affected the splicing of this gene. Conclusions: We have successfully established an induced pluripotent stem cell disease model from a patient with retinitis pigmentosa, enabling molecular characterization of disease mechanisms in normally inaccessible patient tissues. Pathogenicity of the novel CLN3 missense mutation was confirmed by gene correction. Patient-derived retinal cells produced from pluripotent stem cells provide an ideal platform for preclinical drug screening trials. Purpose: Connexin43 hemichannel mediated ATP release activates the NLRP3 inflammasome pathway which underlies chronic inflammation in both wet and dry AMD. Xiflam (Tonabersat) is an orally available benzopyran, initially developed for treatment of migraine. We sought to determine whether Xiflam is a hemichannel blocker, and to demonstrate benefit in an animal model mimicking retinal degeneration in AMD. Methods: Human cerebral microvascular endothelial cells (hCMVEC), with and without Xiflam, were cultured in with an hypoxic, acidic, ion-shifted Ringer injury solution which triggers hemichannel opening and ATP release. Single-channel membrane currents were measured before and after addition of Xiflam, and after washout, following stimulation to positive membrane potentials that activate hemichannel opening. The bright light-induced retinal damage model was used to assess any effects of
